“Exfoliated dermatitis and hepatitis to first line anti-tubercular therapy with treatment of drug-sensitive tuberculosis with second line anti-tubercular therapy: a roller coaster ride” (2024) Chest Disease Reports, 12(1). doi:10.4081/cdr.12.12626.